IPG Photonics Corp
NASDAQ:IPGP

Watchlist Manager
IPG Photonics Corp Logo
IPG Photonics Corp
NASDAQ:IPGP
Watchlist
Price: 81.92 USD -1.13% Market Closed
Market Cap: 3.5B USD

IPG Photonics Corp
Investor Relations

IPG Photonics Corp. stands as a beacon of innovation in the photonics industry, crafting the future with light. Founded in 1990, this technological powerhouse began its journey pioneering the development of fiber lasers, which have since revolutionized countless industries. At the heart of IPG's operations lies its expertise in semiconductor diode lasers, amplifiers, and other photonic technologies. These systems are pivotal in advancing the capabilities of telecommunications, medical science, and industrial manufacturing. By harnessing the power of efficient and versatile fiber lasers, IPG has carved a niche, offering solutions that not only enhance productivity but also drastically reduce costs for its clientele. This focus on innovation and efficiency enables IPG to stay ahead in a competitive market, fulfilling the ever-growing demand for precision and speed in modern-day applications.

Revenue generation at IPG Photonics is centered on its ability to address the complex demands of a diverse set of industries. Their fiber lasers replace traditional light sources in manufacturing, allowing for faster, cleaner, and more accurate cutting and welding operations. This leads to greater efficiency in automotive, aerospace, and electronics manufacturing sectors, where precision and speed are critical. Moreover, IPG's products extend beyond industrial manufacturing into telecommunications, medical devices, and scientific research, broadening their business horizon. As these industries continue to evolve, the demand for reliable and high-performance laser solutions grows, securing a steady pipeline of income for the company. Through a combination of advanced research and a keen eye for market needs, IPG Photonics has positioned itself as a leader in photonics, pushing the boundaries of what lasers can achieve in today's world.

Show more
Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Last Earnings Call
Fiscal Period
Q3 2025
Call Date
Nov 4, 2025
AI Summary
Q3 2025

Revenue: Q3 revenue was $251 million, at the top end of guidance, flat sequentially and up 8% year-over-year (or 11% excluding divestitures).

Profitability: Gross margin improved to 39.5%, above expectations, driven by better manufacturing cost absorption and lower inventory provisions.

EPS & EBITDA: Net income was $7 million ($0.18 per diluted share), with adjusted EPS of $0.35 and adjusted EBITDA of $37 million, all at the top end of guidance.

Outlook: Q4 revenue guidance is $230–$260 million with gross margin expected between 36% and 39%; adjusted EPS guidance is $0.05–$0.35.

Demand Environment: Book-to-bill was around 1; management is ‘cautiously optimistic’ as PMIs improve and industrial activity begins to recover.

Growth Initiatives: Strong progress in medical (FDA-cleared urology laser system), micromachining, and defense (CROSSBOW directed energy system), positioning for future revenue growth.

Capital Allocation: Free cash flow turned positive; company ended Q3 with $870 million in cash and no debt after $21 million CapEx and $16 million share repurchase.

Key Financials
Revenue
$251 million
Gross Margin
39.5%
Operating Income
$8 million
Net Income
$7 million
EPS
$0.18 per diluted share
Adjusted EPS
$0.35 per diluted share
Adjusted EBITDA
$37 million
Cash, Cash Equivalents & Short-term Investments
$870 million
Long-term Investments
$30 million
Capital Expenditures
$21 million
Share Repurchases
$16 million
Book-to-bill Ratio
Approximately 1
Emerging Growth Products Sales Mix
52% of sales in Q3
Earnings Call Recording
Other Earnings Calls

Management

Mr. Timothy P. V. Mammen
Senior VP & CFO
No Bio Available
Mr. Angelo P. Lopresti II
Senior VP, General Counsel & Secretary
No Bio Available
Mr. Trevor D. Ness
Senior Vice President of Sales & Strategic Business Development
No Bio Available
Dr. Eugene A. Scherbakov Ph.D.
Director & Advisor
No Bio Available
Dr. Mark Milton Gitin
CEO & Director
No Bio Available
Mr. Thomas J. Burgomaster
VP, Corporate Controller, Treasurer & Chief Accounting Officer
No Bio Available
Dr. Igor Samartsev Ph.D.
Senior VP & Chief Scientist
No Bio Available
Mr. Eugene Fedotoff
Senior Director of Investor Relations
No Bio Available
John Weaver
Vice President of Human Resources Worldwide
No Bio Available

Contacts

Address
MASSACHUSETTS
Oxford
50 Old Webster Rd
Contacts
+15083731100.0
www.ipgphotonics.com